Jane M. Grant-kels serves as Executive at Veradermics, Inc, where they oversee executive responsibilities. Since joining the company, Jane M. Grant-kels has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 5, 2026 involved exercising options for 2,455 shares valued at $0.
Jane M. Grant-kels currently holds 2,455 shares of Veradermics, Inc (MANE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jane M. Grant-kels has been a net neutral trader of MANE stock. They have purchased $0 and sold $0 worth of shares.
Jane M. Grant-kels's most recent insider trade was on Feb 5, 2026, when they sold 2,455 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 3, 2026 | MANE | $0 | Award | 51,525 | $N/A | Discretionary |